According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Topical Hemostatic Agents Market

The global market for Topical Hemostatic Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the last few years,

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Topical Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Hemostatic Agents.

The Topical Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Topical Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Topical Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Topical Hemostatic Agents Market Report

Report Metric	Details
Report Name	Topical Hemostatic Agents Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Gelation Sponge Oxidized Regenerated Cellulose Based Hemostats Others
Segment by Application	Hospitals Surgical Centers Nursing Homes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Topical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Topical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Topical Hemostatic Agents Market report?

Ans: The main players in the Topical Hemostatic Agents Market are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies

What are the Application segmentation covered in the Topical Hemostatic Agents Market report?

Ans: The Applications covered in the Topical Hemostatic Agents Market report are Hospitals, Surgical Centers, Nursing Homes

What are the Type segmentation covered in the Topical Hemostatic Agents Market report?

Ans: The Types covered in the Topical Hemostatic Agents Market report are Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others

1 Topical Hemostatic Agents Market Overview

1.1 Product Definition

1.2 Topical Hemostatic Agents by Type

1.2.1 Global Topical Hemostatic Agents Market Value Comparison by Type (2024 VS 2031)

1.2.2 Gelation Sponge

1.2.3 Oxidized Regenerated Cellulose Based Hemostats

1.2.4 Others

1.3 Topical Hemostatic Agents by Application

1.3.1 Global Topical Hemostatic Agents Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Surgical Centers

1.3.4 Nursing Homes

1.4 Global Topical Hemostatic Agents Market Size Estimates and Forecasts

1.4.1 Global Topical Hemostatic Agents Revenue 2020-2031

1.4.2 Global Topical Hemostatic Agents Sales 2020-2031

1.4.3 Global Topical Hemostatic Agents Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Topical Hemostatic Agents Market Competition by Manufacturers

2.1 Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2020-2025)

2.2 Global Topical Hemostatic Agents Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Topical Hemostatic Agents Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Topical Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Topical Hemostatic Agents, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Topical Hemostatic Agents, Product Type & Application

2.7 Global Key Manufacturers of Topical Hemostatic Agents, Date of Enter into This Industry

2.8 Global Topical Hemostatic Agents Market Competitive Situation and Trends

2.8.1 Global Topical Hemostatic Agents Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Topical Hemostatic Agents Players Market Share by Revenue

2.8.3 Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Topical Hemostatic Agents Market Scenario by Region

3.1 Global Topical Hemostatic Agents Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Topical Hemostatic Agents Sales by Region: 2020-2031

3.2.1 Global Topical Hemostatic Agents Sales by Region: 2020-2025

3.2.2 Global Topical Hemostatic Agents Sales by Region: 2026-2031

3.3 Global Topical Hemostatic Agents Revenue by Region: 2020-2031

3.3.1 Global Topical Hemostatic Agents Revenue by Region: 2020-2025

3.3.2 Global Topical Hemostatic Agents Revenue by Region: 2026-2031

3.4 North America Topical Hemostatic Agents Market Facts & Figures by Country

3.4.1 North America Topical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Topical Hemostatic Agents Sales by Country (2020-2031)

3.4.3 North America Topical Hemostatic Agents Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Topical Hemostatic Agents Market Facts & Figures by Country

3.5.1 Europe Topical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Topical Hemostatic Agents Sales by Country (2020-2031)

3.5.3 Europe Topical Hemostatic Agents Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Topical Hemostatic Agents Market Facts & Figures by Region

3.6.1 Asia Pacific Topical Hemostatic Agents Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Topical Hemostatic Agents Sales by Region (2020-2031)

3.6.3 Asia Pacific Topical Hemostatic Agents Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Topical Hemostatic Agents Market Facts & Figures by Country

3.7.1 Latin America Topical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Topical Hemostatic Agents Sales by Country (2020-2031)

3.7.3 Latin America Topical Hemostatic Agents Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Topical Hemostatic Agents Market Facts & Figures by Country

3.8.1 Middle East and Africa Topical Hemostatic Agents Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Topical Hemostatic Agents Sales by Country (2020-2031)

3.8.3 Middle East and Africa Topical Hemostatic Agents Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Topical Hemostatic Agents Sales by Type (2020-2031)

4.1.1 Global Topical Hemostatic Agents Sales by Type (2020-2025)

4.1.2 Global Topical Hemostatic Agents Sales by Type (2026-2031)

4.1.3 Global Topical Hemostatic Agents Sales Market Share by Type (2020-2031)

4.2 Global Topical Hemostatic Agents Revenue by Type (2020-2031)

4.2.1 Global Topical Hemostatic Agents Revenue by Type (2020-2025)

4.2.2 Global Topical Hemostatic Agents Revenue by Type (2026-2031)

4.2.3 Global Topical Hemostatic Agents Revenue Market Share by Type (2020-2031)

4.3 Global Topical Hemostatic Agents Price by Type (2020-2031)

5 Segment by Application

5.1 Global Topical Hemostatic Agents Sales by Application (2020-2031)

5.1.1 Global Topical Hemostatic Agents Sales by Application (2020-2025)

5.1.2 Global Topical Hemostatic Agents Sales by Application (2026-2031)

5.1.3 Global Topical Hemostatic Agents Sales Market Share by Application (2020-2031)

5.2 Global Topical Hemostatic Agents Revenue by Application (2020-2031)

5.2.1 Global Topical Hemostatic Agents Revenue by Application (2020-2025)

5.2.2 Global Topical Hemostatic Agents Revenue by Application (2026-2031)

5.2.3 Global Topical Hemostatic Agents Revenue Market Share by Application (2020-2031)

5.3 Global Topical Hemostatic Agents Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Ethicon

6.1.1 Ethicon Company Information

6.1.2 Ethicon Description and Business Overview

6.1.3 Ethicon Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ethicon Topical Hemostatic Agents Product Portfolio

6.1.5 Ethicon Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Topical Hemostatic Agents Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Baxter International

6.3.1 Baxter International Company Information

6.3.2 Baxter International Description and Business Overview

6.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Baxter International Topical Hemostatic Agents Product Portfolio

6.3.5 Baxter International Recent Developments/Updates

6.4 C. R. Bard

6.4.1 C. R. Bard Company Information

6.4.2 C. R. Bard Description and Business Overview

6.4.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.4.4 C. R. Bard Topical Hemostatic Agents Product Portfolio

6.4.5 C. R. Bard Recent Developments/Updates

6.5 The Medicines Company

6.5.1 The Medicines Company Company Information

6.5.2 The Medicines Company Description and Business Overview

6.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.5.4 The Medicines Company Topical Hemostatic Agents Product Portfolio

6.5.5 The Medicines Company Recent Developments/Updates

6.6 Anika Therapeutics

6.6.1 Anika Therapeutics Company Information

6.6.2 Anika Therapeutics Description and Business Overview

6.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Anika Therapeutics Topical Hemostatic Agents Product Portfolio

6.6.5 Anika Therapeutics Recent Developments/Updates

6.7 Advanced Medical Solutions

6.7.1 Advanced Medical Solutions Company Information

6.7.2 Advanced Medical Solutions Description and Business Overview

6.7.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Advanced Medical Solutions Topical Hemostatic Agents Product Portfolio

6.7.5 Advanced Medical Solutions Recent Developments/Updates

6.8 Integra LifeSciences

6.8.1 Integra LifeSciences Company Information

6.8.2 Integra LifeSciences Description and Business Overview

6.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Integra LifeSciences Topical Hemostatic Agents Product Portfolio

6.8.5 Integra LifeSciences Recent Developments/Updates

6.9 B Braun Melsungen

6.9.1 B Braun Melsungen Company Information

6.9.2 B Braun Melsungen Description and Business Overview

6.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.9.4 B Braun Melsungen Topical Hemostatic Agents Product Portfolio

6.9.5 B Braun Melsungen Recent Developments/Updates

6.10 Gelita Medical

6.10.1 Gelita Medical Company Information

6.10.2 Gelita Medical Description and Business Overview

6.10.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Gelita Medical Topical Hemostatic Agents Product Portfolio

6.10.5 Gelita Medical Recent Developments/Updates

6.11 Equimedical

6.11.1 Equimedical Company Information

6.11.2 Equimedical Description and Business Overview

6.11.3 Equimedical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Equimedical Topical Hemostatic Agents Product Portfolio

6.11.5 Equimedical Recent Developments/Updates

6.12 Vascular Solutions

6.12.1 Vascular Solutions Company Information

6.12.2 Vascular Solutions Description and Business Overview

6.12.3 Vascular Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Vascular Solutions Topical Hemostatic Agents Product Portfolio

6.12.5 Vascular Solutions Recent Developments/Updates

6.13 Marine Polymer Technologies

6.13.1 Marine Polymer Technologies Company Information

6.13.2 Marine Polymer Technologies Description and Business Overview

6.13.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Marine Polymer Technologies Topical Hemostatic Agents Product Portfolio

6.13.5 Marine Polymer Technologies Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Topical Hemostatic Agents Industry Chain Analysis

7.2 Topical Hemostatic Agents Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Topical Hemostatic Agents Production Mode & Process Analysis

7.4 Topical Hemostatic Agents Sales and Marketing

7.4.1 Topical Hemostatic Agents Sales Channels

7.4.2 Topical Hemostatic Agents Distributors

7.5 Topical Hemostatic Agents Customer Analysis

8 Topical Hemostatic Agents Market Dynamics

8.1 Topical Hemostatic Agents Industry Trends

8.2 Topical Hemostatic Agents Market Drivers

8.3 Topical Hemostatic Agents Market Challenges

8.4 Topical Hemostatic Agents Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Marine Polymer Technologies

List of Tables

Table 1. Global Topical Hemostatic Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Topical Hemostatic Agents Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Topical Hemostatic Agents Market Competitive Situation by Manufacturers in 2024

Table 4. Global Topical Hemostatic Agents Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Topical Hemostatic Agents Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Topical Hemostatic Agents Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Topical Hemostatic Agents Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Topical Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Topical Hemostatic Agents, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Topical Hemostatic Agents, Product Type & Application

Table 12. Global Key Manufacturers of Topical Hemostatic Agents, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Topical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Hemostatic Agents as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Topical Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Topical Hemostatic Agents Sales by Region (2020-2025) & (K Units)

Table 18. Global Topical Hemostatic Agents Sales Market Share by Region (2020-2025)

Table 19. Global Topical Hemostatic Agents Sales by Region (2026-2031) & (K Units)

Table 20. Global Topical Hemostatic Agents Sales Market Share by Region (2026-2031)

Table 21. Global Topical Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Topical Hemostatic Agents Revenue Market Share by Region (2020-2025)

Table 23. Global Topical Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Topical Hemostatic Agents Revenue Market Share by Region (2026-2031)

Table 25. North America Topical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Topical Hemostatic Agents Sales by Country (2020-2025) & (K Units)

Table 27. North America Topical Hemostatic Agents Sales by Country (2026-2031) & (K Units)

Table 28. North America Topical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Topical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Topical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Topical Hemostatic Agents Sales by Country (2020-2025) & (K Units)

Table 32. Europe Topical Hemostatic Agents Sales by Country (2026-2031) & (K Units)

Table 33. Europe Topical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Topical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Topical Hemostatic Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Topical Hemostatic Agents Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Topical Hemostatic Agents Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Topical Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Topical Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Topical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Topical Hemostatic Agents Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Topical Hemostatic Agents Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Topical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Topical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Topical Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Topical Hemostatic Agents Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Topical Hemostatic Agents Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Topical Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Topical Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Topical Hemostatic Agents Sales (K Units) by Type (2020-2025)

Table 51. Global Topical Hemostatic Agents Sales (K Units) by Type (2026-2031)

Table 52. Global Topical Hemostatic Agents Sales Market Share by Type (2020-2025)

Table 53. Global Topical Hemostatic Agents Sales Market Share by Type (2026-2031)

Table 54. Global Topical Hemostatic Agents Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Topical Hemostatic Agents Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Topical Hemostatic Agents Revenue Market Share by Type (2020-2025)

Table 57. Global Topical Hemostatic Agents Revenue Market Share by Type (2026-2031)

Table 58. Global Topical Hemostatic Agents Price (USD/Unit) by Type (2020-2025)

Table 59. Global Topical Hemostatic Agents Price (USD/Unit) by Type (2026-2031)

Table 60. Global Topical Hemostatic Agents Sales (K Units) by Application (2020-2025)

Table 61. Global Topical Hemostatic Agents Sales (K Units) by Application (2026-2031)

Table 62. Global Topical Hemostatic Agents Sales Market Share by Application (2020-2025)

Table 63. Global Topical Hemostatic Agents Sales Market Share by Application (2026-2031)

Table 64. Global Topical Hemostatic Agents Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Topical Hemostatic Agents Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Topical Hemostatic Agents Revenue Market Share by Application (2020-2025)

Table 67. Global Topical Hemostatic Agents Revenue Market Share by Application (2026-2031)

Table 68. Global Topical Hemostatic Agents Price (USD/Unit) by Application (2020-2025)

Table 69. Global Topical Hemostatic Agents Price (USD/Unit) by Application (2026-2031)

Table 70. Ethicon Company Information

Table 71. Ethicon Description and Business Overview

Table 72. Ethicon Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Ethicon Topical Hemostatic Agents Product

Table 74. Ethicon Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Topical Hemostatic Agents Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Baxter International Company Information

Table 81. Baxter International Description and Business Overview

Table 82. Baxter International Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Baxter International Topical Hemostatic Agents Product

Table 84. Baxter International Recent Developments/Updates

Table 85. C. R. Bard Company Information

Table 86. C. R. Bard Description and Business Overview

Table 87. C. R. Bard Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. C. R. Bard Topical Hemostatic Agents Product

Table 89. C. R. Bard Recent Developments/Updates

Table 90. The Medicines Company Company Information

Table 91. The Medicines Company Description and Business Overview

Table 92. The Medicines Company Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. The Medicines Company Topical Hemostatic Agents Product

Table 94. The Medicines Company Recent Developments/Updates

Table 95. Anika Therapeutics Company Information

Table 96. Anika Therapeutics Description and Business Overview

Table 97. Anika Therapeutics Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Anika Therapeutics Topical Hemostatic Agents Product

Table 99. Anika Therapeutics Recent Developments/Updates

Table 100. Advanced Medical Solutions Company Information

Table 101. Advanced Medical Solutions Description and Business Overview

Table 102. Advanced Medical Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Advanced Medical Solutions Topical Hemostatic Agents Product

Table 104. Advanced Medical Solutions Recent Developments/Updates

Table 105. Integra LifeSciences Company Information

Table 106. Integra LifeSciences Description and Business Overview

Table 107. Integra LifeSciences Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Integra LifeSciences Topical Hemostatic Agents Product

Table 109. Integra LifeSciences Recent Developments/Updates

Table 110. B Braun Melsungen Company Information

Table 111. B Braun Melsungen Description and Business Overview

Table 112. B Braun Melsungen Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. B Braun Melsungen Topical Hemostatic Agents Product

Table 114. B Braun Melsungen Recent Developments/Updates

Table 115. Gelita Medical Company Information

Table 116. Gelita Medical Description and Business Overview

Table 117. Gelita Medical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Gelita Medical Topical Hemostatic Agents Product

Table 119. Gelita Medical Recent Developments/Updates

Table 120. Equimedical Company Information

Table 121. Equimedical Description and Business Overview

Table 122. Equimedical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Equimedical Topical Hemostatic Agents Product

Table 124. Equimedical Recent Developments/Updates

Table 125. Vascular Solutions Company Information

Table 126. Vascular Solutions Description and Business Overview

Table 127. Vascular Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Vascular Solutions Topical Hemostatic Agents Product

Table 129. Vascular Solutions Recent Developments/Updates

Table 130. Marine Polymer Technologies Company Information

Table 131. Marine Polymer Technologies Description and Business Overview

Table 132. Marine Polymer Technologies Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Marine Polymer Technologies Topical Hemostatic Agents Product

Table 134. Marine Polymer Technologies Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Topical Hemostatic Agents Distributors List

Table 138. Topical Hemostatic Agents Customers List

Table 139. Topical Hemostatic Agents Market Trends

Table 140. Topical Hemostatic Agents Market Drivers

Table 141. Topical Hemostatic Agents Market Challenges

Table 142. Topical Hemostatic Agents Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Topical Hemostatic Agents

Figure 2. Global Topical Hemostatic Agents Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Topical Hemostatic Agents Market Share by Type: 2024 & 2031

Figure 4. Gelation Sponge Product Picture

Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture

Figure 6. Others Product Picture

Figure 7. Global Topical Hemostatic Agents Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Topical Hemostatic Agents Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Surgical Centers

Figure 11. Nursing Homes

Figure 12. Global Topical Hemostatic Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Topical Hemostatic Agents Market Size (2020-2031) & (US$ Million)

Figure 14. Global Topical Hemostatic Agents Sales (2020-2031) & (K Units)

Figure 15. Global Topical Hemostatic Agents Average Price (USD/Unit) & (2020-2031)

Figure 16. Topical Hemostatic Agents Report Years Considered

Figure 17. Topical Hemostatic Agents Sales Share by Manufacturers in 2024

Figure 18. Global Topical Hemostatic Agents Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Topical Hemostatic Agents Players: Market Share by Revenue in Topical Hemostatic Agents in 2024

Figure 20. Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Topical Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Topical Hemostatic Agents Sales Market Share by Country (2020-2031)

Figure 23. North America Topical Hemostatic Agents Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Topical Hemostatic Agents Sales Market Share by Country (2020-2031)

Figure 27. Europe Topical Hemostatic Agents Revenue Market Share by Country (2020-2031)

Figure 28. Germany Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Topical Hemostatic Agents Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Region (2020-2031)

Figure 35. China Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Topical Hemostatic Agents Sales Market Share by Country (2020-2031)

Figure 46. Latin America Topical Hemostatic Agents Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Topical Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Topical Hemostatic Agents by Type (2020-2031)

Figure 56. Global Revenue Market Share of Topical Hemostatic Agents by Type (2020-2031)

Figure 57. Global Topical Hemostatic Agents Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Topical Hemostatic Agents by Application (2020-2031)

Figure 59. Global Revenue Market Share of Topical Hemostatic Agents by Application (2020-2031)

Figure 60. Global Topical Hemostatic Agents Price (USD/Unit) by Application (2020-2031)

Figure 61. Topical Hemostatic Agents Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions